103 related articles for article (PubMed ID: 11169899)
1. Calretinin immunostaining in benign and malignant pleural effusions.
Simsir A; Fetsch P; Abati A
Diagn Cytopathol; 2001 Feb; 24(2):149-52. PubMed ID: 11169899
[No Abstract] [Full Text] [Related]
2. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless.
Simsir A; Fetsch P; Mehta D; Zakowski M; Abati A
Diagn Cytopathol; 1999 Mar; 20(3):125-30. PubMed ID: 10086235
[TBL] [Abstract][Full Text] [Related]
4. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
[TBL] [Abstract][Full Text] [Related]
5. EZH2, a unique marker of malignancy in effusion cytology.
Jiang H; Gupta R; Somma J
Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
[TBL] [Abstract][Full Text] [Related]
6. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.
He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS
World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary adenocarcinoma simulating malignant mesothelioma.
Tang P; Vatsia SK; Teichberg S; Kahn E
Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
[TBL] [Abstract][Full Text] [Related]
9. Unusual clear cell variant of epithelioid mesothelioma.
Dessy E; Falleni M; Braidotti P; Del Curto B; Panigalli T; Pietra GG
Arch Pathol Lab Med; 2001 Dec; 125(12):1588-90. PubMed ID: 11735696
[TBL] [Abstract][Full Text] [Related]
10. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
[TBL] [Abstract][Full Text] [Related]
11. Calretinin: a novel immunocytochemical marker for mesothelioma.
Doglioni C; Dei Tos AP; Laurino L; Iuzzolino P; Chiarelli C; Celio MR; Viale G
Am J Surg Pathol; 1996 Sep; 20(9):1037-46. PubMed ID: 8764740
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mesothelioma in bronchioalveolar lavage: a case report.
Akinfolarin J; Black A; Al-Abbadi M
Diagn Cytopathol; 2008 Mar; 36(3):190-2. PubMed ID: 18232009
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Auto Cyto Fix (membrane filter method) for the application of immunohistochemistry.
Iijima J; Shiina Y; Ohkoudo M; Sakuma K
Diagn Cytopathol; 2002 Jan; 26(1):56-60. PubMed ID: 11782090
[TBL] [Abstract][Full Text] [Related]
14. [The value of immunocytochemistry in differentiating benign and malignant serous effusion].
Mei P; Luo XL; Liu YH; Zhuang HG; Zhang W; Chen GY
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):368-9. PubMed ID: 16185510
[No Abstract] [Full Text] [Related]
15. Glycogen-rich mesothelioma.
Ordóñez NG; Mackay B
Ultrastruct Pathol; 1999; 23(6):401-6. PubMed ID: 10626691
[TBL] [Abstract][Full Text] [Related]
16. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
Carella R; Deleonardi G; D'Errico A; Salerno A; Egarter-Vigl E; Seebacher C; Donazzan G; Grigioni WF
Am J Surg Pathol; 2001 Jan; 25(1):43-50. PubMed ID: 11145250
[TBL] [Abstract][Full Text] [Related]
18. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
19. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
20. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
